Remove Contamination Remove Genetics Remove Packaging
article thumbnail

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.

Genomics 244
article thumbnail

FDA In Brief: FDA Announces Investigation of a Third Outbreak of E. coli O157:H7

The Pharma Data

coli O157:H7 strain found by Michigan Department of Agriculture and Rural Development (MDARD) in Tanimura & Antle brand packaged single head romaine lettuce. It is important to note that the E.coli strain identified in this outbreak is not genetically related to either of the E. 15 or 16 due to possible contamination with E.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Outsourcing Biologics Fill Finish Manufacturing : Streamlining the Production Process for Biopharmaceutical Companies

Roots Analysis

Over the years, these large molecules have demonstrated promising therapeutic outcomes in the treatment of myriad of chronic and challenging disorders, including autoimmune disorders, infectious diseases, genetic disorders, and oncological disorders.

article thumbnail

101 Toxic Food Ingredients – New Conversion Breakthrough

The Pharma Data

FACT: A recent study conducted by the Grocery Manufacturer’s Association states that OVER 80% of packaged foods eaten in the U.S. every day are contaminated with at LEAST ONE TOXIC ingredient. The REAL problem lies in the fact that most of the foods we eat today have been Genetically Modified. A better definition of a G.M.O.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

CanSino Biologics is developing a vaccine that involves snipping a bit of the virus’ genetic code off and coupling it with a harmless virus to provoke a SARS-CoV-2 immune response. The package is made up of a €390 billion fund in grants and a €360 billion in low interest loans. And stimulus packages continue.

Vaccine 92